Protara Therapeutics Inc (NASDAQ: TARA) is -13.83% lower on its value in year-to-date trading and has touched a low of $1.60 and a high of $10.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TARA stock was last observed hovering at around $4.63 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $4.55, the stock is -14.82% and 5.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.24 million and changing -1.73% at the moment leaves the stock 58.71% off its SMA200. TARA registered 105.88% gain for a year compared to 6-month gain of 101.33%. The firm has a 50-day simple moving average (SMA 50) of $4.329 and a 200-day simple moving average (SMA200) of $2.866825.
The stock witnessed a -17.72% loss in the last 1 month and extending the period to 3 months gives it a 144.62%, and is -18.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.32% over the week and 7.73% over the month.
Protara Therapeutics Inc (TARA) has around 27 employees, a market worth around $156.15M and $0.00M in sales. Distance from 52-week low is 185.27% and -56.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-49.21%).
The EPS is expected to grow by 7.10% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Protara Therapeutics Inc (TARA) Top Institutional Holders
45.0 institutions hold shares in Protara Therapeutics Inc (TARA), with institutional investors hold 54.45% of the company’s shares. The shares outstanding are 34.32M, and float is at 32.07M with Short Float at 15.90%. Institutions hold 51.11% of the Float.
The top institutional shareholder in the company is OPALEYE MANAGEMENT INC. with over 2.3 million shares valued at $5.3 million. The investor’s holdings represent 20.1758% of the TARA Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 1.9 million shares valued at $3.95 million to account for 16.6361 of the shares outstanding. The other top investors are STEMPOINT CAPITAL LP which holds 0.98 million shares representing 8.6167% and valued at over $2.05 million, while BOXER CAPITAL, LLC holds 7.1065 of the shares totaling 0.81 million with a market value of $1.69 million.
Protara Therapeutics Inc (TARA) Insider Activity
The most recent transaction is an insider sale by Opaleye Management Inc., the company’s 10% Owner. SEC filings show that Opaleye Management Inc. sold 126,301 shares of the company’s common stock on Sep 12 ’24 at a price of $1.71 per share for a total of $0.22 million. Following the sale, the insider now owns 45000.0 shares.
Protara Therapeutics Inc disclosed in a document filed with the SEC on Sep 11 ’24 that Opaleye Management Inc. (10% Owner) sold a total of 32,600 shares of the company’s common stock. The trade occurred on Sep 11 ’24 and was made at $1.71 per share for $55880.0. Following the transaction, the insider now directly holds 51500.0 shares of the TARA stock.
Still, SEC filings show that on Sep 09 ’24, Opaleye Management Inc. (10% Owner) disposed off 36,492 shares at an average price of $1.89 for $69141.0. The insider now directly holds 54,600 shares of Protara Therapeutics Inc (TARA).
